MBX Biosciences Inc. said its CEO Kent Hawryluk and CMO Sam Azoulay will participate in four March investor conferences in Miami, Florida: the Citizens Life Sciences Conference on March 10, 2026 (including a 9:00–9:25 a.m. ET fireside chat), the UBS Biotech Summit Miami – Catalyst for Change on March 10, 2026 (1x1 meetings only), the Jefferies Biotech on the Beach Summit on March 11, 2026 (1x1 meetings only), and the Barclays 28th Global Healthcare Conference on March 11, 2026 (including a 3:00–3:25 p.m. ET fireside chat). Webcasts, where available, will be accessible via https://investors.mbxbio.com/news-events/events.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MBX Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9658509-en) on February 23, 2026, and is solely responsible for the information contained therein.